The company has developed more than 2 new Chinese patent medicines, including Shufeng Jiedu Capsule, Penyanjing Tablet, Compound Puqin Capsule, Jiangzhining Tablet, Pudilan Xiaoyan Tablet, Yankening Tablet, Fuyuekang Capsule, Gongyankang Granule, Kangerling Granule, Niaoseitong Tablet, Pharyngeal Buccal Tablet, Metoprolol Tartrate Sustained-release Tablet, Tongbianling Capsule, Diedahong Tablet and Huihui Tablet. In particular, on January 4th, 29, the approval of Shufeng Jiedu Capsule, the original third-class national new drug with exclusive independent intellectual property rights, will play a vital role in the company's future development. At present, the company is researching Xinyi Capsule, Gengnianshu Tablet, Fengtongan Capsule, Suke Ganmao Tablet, Aidiconazole, Shiwei Jiangtang Tablet and other products. Among them, Aidiconazole is a new drug of national chemical innovation, and it has been supported by the major scientific and technological projects of the Central Military Commission.